Lobbying Information
Subject Matters
- Aboriginal Affairs
- Health
- Industry
- Intellectual Property
- International Trade
- Science and Technology
- Taxation and Finance
Subject Matter Details
Legislative Proposal, Bill or Resolution, Policies or Program
- Pharmaceutical intellectual property proposals that are part of the Comprehensive Economic and Trade Agreement with the European Union.
Legislative Proposal, Bill or Resolution, Policies or Program, Regulation
- Acts that propose to amend the Food and Drug Act and amendments to the Food and Drug Regulations related to the regulation of pharmaceuticals, biologic therapies, medical devices and foods.
- Innovation, Science and Economic Development Canada (PMNOC) Regulations, as this relates to regulating intellectual property of prescription drugs; as well as discussions pertaining to growth and development of the life sciences industry in Canada, including as part of an Innovation Agenda.
Legislative Proposal, Bill or Resolution, Regulation
- Similar Entry Biologics (SEBs): requiring a Health Canada regulatory framework that support the approval of SEBs
Policies or Program
- Common Drug Review (CDR), with respect to health economics assessment and recommendations made on new medicines.
- Federal Government Non Insured Health Benefits program with respect to reimbursement of a prescription medicine and changes in type of reimbursement
- Public Health Agency of Canada, regarding the federal response to the hepatitis C virus.
Regulation
- Patented Medicine Prices Review Board (PMPRB) Regulations.
with regard to prices charged by patentees for patented medicines sold in Canada.
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Canadian Institutes of Health Research (CIHR)
-
Correctional Service of Canada (CSC)
-
Employment and Social Development Canada (ESDC)
-
Finance Canada (FIN)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Immigration and Refugee Board (IRB)
-
Indigenous and Northern Affairs Canada
-
Innovation, Science and Economic Development Canada (ISED)
-
National Defence (DND)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Public Health Agency of Canada (PHAC)
-
Public Services and Procurement Canada (PSPC)
-
Royal Canadian Mounted Police (RCMP)
-
Senate of Canada
-
Veterans Affairs Canada (VAC)
In-house Corporation Details
Description of activities
AbbVie is a global, research-based biopharmaceutical company formed in 2013. We use our expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.
Responsible officer name and position during the period of this registration
Stéphane Lassignardie,
General Manager
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
8401 Transcanada Highway
St-Laurent, QC H4S 1Z1
Canada
Telephone number:
514-832-7126
Fax number:
514-832-7858
Parent Company Information
- AbbVie
-
100 Abbott Park Rd
Abbott Park, IL 60064-3500
United States of America
Subsidiary Beneficiary Information
AbbVie Corporation does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Loretta Del Bosco,
Director, Regulatory Affairs & Quality Assurance |
No public offices held
- Katherine Emrich,
Director, Market Access & Government Affairs |
No public offices held
- Caroline Jacques,
Senior Counsel, Canada |
No public offices held
- Stéphane Lassignardie,
General Manager |
No public offices held
- David Link,
Regional Manager Market Access & Government Affairs |
No public offices held
- Judith Mergl,
Senior Manager Regulatory Affairs |
No public offices held
- Diana Parison,
Regional Manager Market Access & Government Affairs |
No public offices held
- Christina Pelizon,
Medical Director |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- Catherine Robert,
Senior Manager, Market Access and Health Economics |
No public offices held
- Paul Sutton,
Senior Manager, Government Affairs |
No public offices held